Cellecta

Founded in 2006 by senior scientists from Clontech Laboratories, Cellecta, Inc. is a premier provider of advanced functional genomics products and services. The company was established to address the critical industry need for higher-quality, complex lentiviral libraries and high-throughput (HT) genetic screening technologies. Today, Cellecta is a trusted industry leader dedicated to accelerating drug discovery, identifying novel therapeutic targets, and decoding complex biological pathways for researchers across the globe. Cellecta’s cutting-edge portfolio features an extensive range of off-the-shelf and highly customized products, including custom and genome-wide pooled lentiviral shRNA, CRISPR knockout, and dual-sgRNA CRISPRa/i libraries. Their proprietary technologies—such as the CloneTracker XP™ expressed lentiviral barcode libraries—enable precise clonal tracking and high-resolution variant analysis. By maintaining a rigorous standard for scientific excellence and data reproducibility, Cellecta empowers life science laboratories with the robust, scalable tools necessary to drive the next generation of biomedical breakthroughs.